Disc Medicine, Inc. (IRON) NASDAQ
68.34
+2.54(+3.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
68.34
+2.54(+3.86%)
Currency In USD
Address
321 Arsenal Street
Watertown, MA 02472
United States of America (the)
Phone
617 674 9274
Website
Sector
Healthcare
Industry
Biotechnology
Employees
94
First IPO Date
August 12, 2020
| Name | Title | Pay | Year Born |
| John D. Quisel | Chief Executive Officer, President & Director | 1.26M | 1971 |
| Brian MacDonald | Founder & Chair of Scientific Advisory Board | 88,542 | 1961 |
| Donald William Nicholson | Executive Chairman | 170,000 | 1958 |
| Jonathan Yu | Chief Opearating Officer | 811,560 | 1981 |
| Pamela Stephenson | Chief Commercial Officer | 832,100 | 1968 |
| William Jacob Savage | Chief Medical Officer | 836,840 | 1974 |
| Jean Franchi | Chief Financial Officer | 838,980 | 1966 |
| Srikanth Venkatraman | Senior Vice President & Head of Chemistry | 0 | N/A |
| Hua Yang | Senior Vice President & Head of Early Development and Clinical Pharmacology | 0 | N/A |
| Lisa Amaya Price | Chief Human Resources Officer | 0 | N/A |
| Sonia Razzetti | Senior Vice President of Quality | 0 | N/A |
| Rahul Khara | Chief Legal Officer & Secretary | 0 | 1982 |
| Rahul Rajan Kaushik | Chief Technical Officer | 0 | N/A |
| Steven Caffé | Chief Regulatory Officer | 0 | 1960 |
| Joseph Beaulieu | Senior Vice President of Finance | 0 | 1981 |
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.